Published in Cancer Weekly, September 7th, 1998
The FDA approved thalidomide for use against leprosy, with the tacit acceptance that the drug would in fact be used more often in experimental therapy for a range of disease from cancer to AIDS to rheumatoid arthritis.
"We can't promote it (for these other uses), but we can sell it," said Sol Barer, of New Jersey-based Celgene Corp., which makes thalidomide under the name Thalomid. The approval makes it easier to control the drug, he said. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.